{
  "LUAD": {
    "Glandular Patterns": "Gland-like structures; tubular; acinar; papillary formations; lined by atypical cells; mucin production",
    "Lepidic Growth": "Alveolar growth pattern; non-invasive; early adenocarcinomas; minimally invasive adenocarcinomas",
    "Papillary Structures": "Papillary architecture; fibrovascular cores; malignant cells lining; mucin content",
    "Micropapillary Features": "Micropapillary pattern; small cell clusters; no fibrovascular core; clear spaces from tissue processing",
    "Solid Growth with Mucin": "Solid growth pattern with mucin; mucicarmine; periodic acid-Schiff stains usage",
    "Growth Along Alveolar Walls": "Lepidic growth pattern; tumor cells along alveolar walls; non-invasive",
    "Cellular and Nuclear Features": "Cell morphology variable; cuboidal to columnar shape; hobnail appearance; pleomorphic nuclei; prominent nucleoli",
    "Scar Carcinoma": "Association with lung scarring or fibrosis; possible misdiagnosis on imaging; requires biopsy",
    "EGFR Protein Overexpression": "EGFR expression; membranous staining; possible cytoplasmic staining; cell membrane receptor",
    "ALK Fusions": "ALK IHC; cytoplasmic staining; granular or diffuse; ALK protein detection",
    "KRAS Protein Overexpression": "KRAS protein expression; cytoplasmic staining; inner cell membrane association",
    "PD-L1 Protein Levels": "PD-L1 staining; membranous staining; cell surface expression; therapeutic implications; possible cytoplasmic staining",
    "MET Gene Amplification": "MET receptor tyrosine kinase; crisp linear membranous staining; overexpression indication",
    "Lack of STK11 Gene": "STK11 expression loss; null pattern; no staining in tumor; deletions in KRAS mutations association",
    "TP53 Protein Overexpression": "p53 staining; low/moderate nuclear staining wild-type; strong/extensive or no staining abnormal; TP53 mutation indication",
    "BRCA1-associated protein Mutations": "BAP1 loss; null pattern; no nuclear staining in tumor; non-tumor cells positive; DNA repair difficulty; oncogenesis",
    "Epithelial-to-mesenchymal Transition": "E-cadherin staining decrease; mesenchymal markers increase; cytoplasmic/membranous staining; EMT at invasive front",
    "ABCA3 Protein Overexpression": "ABCA3 overexpression; fine granular cytoplasmic; linear membranous staining; marked increase in alveolar type II cells",
    "THBS Protein Overexpression": "THBS1 localization; granular pattern; extracellular matrix; secreted by cells; angiogenesis inhibition; tumor growth suppression",
    "High Expression of Metabolic Genes": "Metabolic enzyme staining; location-specific (cytoplasmic, membranous, nuclear); example glycolysis enzymes cytoplasmic",
    "DNA Methylation": "DNMTs nuclear localization; nuclear staining; DNA methylation at CpG sites; tumor suppressor gene hypermethylation",
    "Histone Modifications": "Histone modification indication; nuclear staining; DNA packaging in chromatin",
    "Non-Coding RNAs": "ncRNAs localization; nucleus or cytoplasm; miRNAs typically cytoplasmic; lncRNAs variable",
    "Chromatin Remodeling": "Chromatin remodeling proteins; nuclear staining; gene accessibility; SWI/SNF mutations; altered gene expression",
    "Immune Cells": "Immune cell markers; CD3, CD4, CD8 (T cells), CD20 (B cells), CD68 (macrophages); cell type-specific staining; tumor microenvironment",
    "Fibroblasts": "\u03b1-SMA marker; cancer-associated fibroblasts (CAFs); cytoplasmic staining in fibroblasts"
  },
  "LUSC": {
    "Keratinization and Intercellular Bridges": "Squamous differentiation; keratin production; keratin pearls; intercellular bridges",
    "Cell Morphology": "Polygonal tumor cells; abundant eosinophilic cytoplasm; high keratin content",
    "Nuclear Characteristics": "Hyperchromatic nuclei; prominent nucleoli; variable pleomorphism",
    "Increased Cellular and Nuclear Pleomorphism": "Cellular and nuclear pleomorphism; increased variability; indicative of higher malignancy; IHC highlighted",
    "High Mitotic Rate": "High mitotic figure count; rapid cell proliferation; visualized by mitotic markers",
    "Loss of Differentiation Markers": "Differentiation marker loss; less differentiated tumor; more aggressive; IHC assessment",
    "p53 Overexpression": "TP53 mutation; p53 protein overexpression; higher grade tumor indication; IHC detection",
    "CDKN1A Protein Overexpression": "CDKN1A (p21) nuclear staining increase; nuclear protein; p21-specific antibody usage",
    "SOX2 Protein Overexpression": "SOX2 intense nuclear staining; transcription factor; localized in nucleus; notable at invasive tumor edges",
    "Invasion Depth": "Deeper tissue invasion; higher grade tumor; IHC staining of tumor-stromal boundaries",
    "Tumor Budding": "Tumor budding presence; aggressive behavior indicator; cytokeratin stains highlight",
    "Vascular and Lymphatic Invasion": "Tumor cells in blood vessels or lymphatics; potential for metastasis; CD31 and podoplanin (D2-40) markers",
    "High Ki-67 Index": "Ki-67 high labeling index; cellular proliferation marker; correlated with high-grade tumors; poor prognosis",
    "Overexpression of Growth Factor Receptors": "Growth factor receptors high levels; EGFR; VEGFR; aggressive cancer behavior; IHC detection",
    "Reduced Expression of Cell Adhesion Molecules": "E-cadherin reduced expression; epithelial-mesenchymal transition (EMT); increased invasiveness and metastasis; IHC detection",
    "Expression of Metastasis-Related Proteins": "N-cadherin and vimentin upregulation; EMT involvement; cell migration; malignant phenotype; IHC detection",
    "Desmoplastic Stroma": "Reactive stromal response; dense fibrous stroma surrounding tumor cells",
    "Intraepithelial Tumor Growth": "Intraepithelial growth; tumor spread within epithelial structures",
    "Endobronchial Growth": "Endobronchial growth; visible during bronchoscopy; growth within bronchial lumen",
    "Cavitation": "Cavitation; central necrosis; more common in squamous cell carcinoma; visible on imaging",
    "Density of Inflammatory Cells": "High density of inflammatory cells; lymphocytes; macrophages; dendritic cells; neutrophils; within tumor microenvironment (TME)",
    "Tumor-Associated Lymphocytes": "Tumor-infiltrating lymphocytes (TILs); indicative of immune infiltration; predominantly T cells; CD8+ cytotoxic T cells; CD4+ helper T cells; favorable prognosis",
    "Immune Cell Clusters": "Immune cell clusters; invasive margin; active immune surveillance; B cells; tertiary lymphoid structures; lymph node-like organization",
    "Expression of Immune Checkpoint Proteins": "Immune checkpoint proteins overexpression; PD-L1; altered immune pathways; immune evasion; detectable by IHC",
    "Distribution Pattern": "Immune cell distribution; diffuse infiltration favorable; marginal/patchy less favorable",
    "Immune Cell Morphology": "Activated immune cell morphology; larger nuclei; visible nucleoli; abundant cytoplasm"
  }
}